South Dakota § 58-17-101 Insurer may not exclude certain off

South Dakota Statutes

§ 58-17-101 — Insurer may not exclude certain off

South Dakota § 58-17-101

Title 58INSURANCE

Ch. 58-13HEALTH INSURANCE POLICIES

This text of South Dakota § 58-17-101 (Insurer may not exclude certain off) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.D. Codified Laws § 58-17-101 (2026).

Text

No health insurer issuing a policy which provides coverage for prescription drugs may exclude coverage of any drug used for the treatment of cancer or life threatening conditions on the grounds that the drug has not been approved by the FDA for that indication if that drug is recognized for treatment of such indication in one of the standard reference compendia or in the medical literature. The prescribing physician shall submit documentation supporting the proposed off - label use or uses to the insurer, if requested. Any coverage of a drug that serves as the primary treatment required by §§ 58-17-100 to 58-17-106 , inclusive, shall also include medically necessary services associated with the administration of the drug.

Free access — add to your briefcase to read the full text and ask questions with AI

No health insurer issuing a policy which provides coverage for prescription drugs may exclude coverage of any drug used for the treatment of cancer or life threatening conditions on the grounds that the drug has not been approved by the FDA for that indication if that drug is recognized for treatment of such indication in one of the standard reference compendia or in the medical literature. The prescribing physician shall submit documentation supporting the proposed off - label use or uses to the insurer, if requested. Any coverage of a drug that serves as the primary treatment required by §§ 58-17-100 to 58-17-106 , inclusive, shall also include medically necessary services associated with the administration of the drug.